Safety of ALK Ragweed Tablet

Completed · Phase 1

Conditions studied: Allergy

In brief

This trial is performed to assess whether ALK Ragweed Tablet is safe to use in adults

Key facts

Study ID

NCT00330083

Run by

ALK-Abelló A/S

People needed

72

Starts

2006-05-01

Last updated by the study team

2007-09-21

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ragweed pollen induced rhinoconjunctivitis
• Adults of either sex (18-50 years of age)
• Positive skin prick test to ragweed

You may not qualify if…

• Previous treatment with immunotherapy

Where it is running

• Healthcare Discoveries Inc. — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.